FDA Approves Trials of Deep Brain Stimulation for AD

After promising results with Parkinson's patients, researchers are trying the new therapeutic approach against Alzheimer's.

The U.S. Food and Drug Administration (FDA) has given the go-ahead for research trials to determine whether deep brain stimulation (DBS)—a procedure involving the implantation in the brain of a pacemaker-like device—can halt or slow the progression of Alzheimer’s disease (AD). The technique has been used with success in the treatment of symptoms of Parkinson’s […]

Tags , , , , , , , , , , , , , , ,
Comments

Leave a Reply

Enter Your Log In Credentials
This setting should only be used on your home or work computer.

×